KLRK1 and nasopharyngeal carcinoma: One study indicated that there was no difference between the percentage of NKG2D+ NK cells (activated) and KIR2DL2/DL3+NK2GA+ NK cells (inhibited) in peripheral blood samples of NPC patients and a healthy control.